Rocket Pharmaceuticals, Inc.

8-K Regulation FD disclosure Aug 3, 2026 8-K Director or officer change Jun 30, 2026 8-K Completed an acquisition or disposition; Regulation FD disclosure Jun 12, 2026 8-K Shareholder vote results May 21, 2026 8-K Results of operations (earnings release) May 7, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Entered a material agreement; Regulation FD disclosure Apr 28, 2026 8-K Regulation FD disclosure Mar 27, 2026 8-K Entered a material agreement; Terminated a material agreement Mar 10, 2026 8-K Results of operations (earnings release) Feb 26, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Other events Oct 14, 2025 8-K Director or officer change Oct 3, 2025 8-K Other events Oct 3, 2025 8-K Director or officer change Sep 29, 2025 8-K Entered a material agreement Sep 17, 2025 8-K Director or officer change Aug 25, 2025 8-K Other events Aug 20, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release); Director or officer change Aug 7, 2025 8-K Other events Jul 24, 2025 8-K Exit or disposal costs Jul 23, 2025 8-K Other events Jul 17, 2025 8-K Director or officer change Jul 11, 2025 8-K Shareholder vote results Jun 18, 2025 8-K Regulation FD disclosure May 27, 2025 8-K Regulation FD disclosure; Other events May 15, 2025 8-K Results of operations (earnings release) May 8, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Director or officer change Apr 29, 2025 8-K Director or officer change Apr 7, 2025 8-K Results of operations (earnings release) Feb 27, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Director or officer change Jan 28, 2025 8-K Entered a material agreement; Other events Dec 12, 2024 8-K Director or officer change Dec 5, 2024 8-K Regulation FD disclosure; Other events Nov 18, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024